Treatment-free Remission Accomplished With Dasatinib in Patients With CML
Phase of Trial: Phase II
Latest Information Update: 12 Dec 2017
At a glance
- Drugs Dasatinib (Primary) ; Imatinib
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- Acronyms TRAD
- 12 Dec 2017 Interim results (n=107) assesing correlation of RFS with IM discontinuation presented at the 59th Annual Meeting and Exposition of the American Society of Hematology.
- 06 Dec 2016 Preliminary results (n=75) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
- 26 Jun 2015 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.